Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01004055 · ClinicalTrials.gov registry record · Phase 2
Efficacy Study of a Bioelectric Dressing to Treat Wounds Caused by Curettage and Electrodesiccation
A Phase 2 study, sponsored by Vomaris Innovations.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT01004055 is a Phase 2 study that has completed, run by Vomaris Innovations. The registered enrollment target is 15 participants.
The verdict
NCT01004055, a Phase 2 study, has completed, sponsored by Vomaris Innovations.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a bioelectric wound dressing, a silver-coated dressing, or a silver-foam dressing are effective in the treatment of wounds resulting from curettage and electrodesiccation of skin lesions.
Interventions
- DEVICE Procellera™ Antimicrobial Wound Dressing
- DRUG ACTICOAT™ Antimicrobial Barrier Dressing
- DRUG Mepilex® Ag Silver Foam Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01004055
The ClinicalTrials.gov registry entry for NCT01004055 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vomaris Innovations, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Procellera™ Antimicrobial Wound Dressing is the first listed.
NCT01004055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01004055 about?
NCT01004055 is a clinical study titled "Efficacy Study of a Bioelectric Dressing to Treat Wounds Caused by Curettage and Electrodesiccation". The purpose of this study is to determine whether a bioelectric wound dressing, a silver-coated dressing, or a silver-foam dressing are effective in the treatment of wounds resulting from curettage and electrodesiccation of skin lesions.
What is the current status of trial NCT01004055?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2008-07. Estimated completion is 2009-10.
What interventions are being tested in trial NCT01004055?
The interventions under investigation include: Procellera™ Antimicrobial Wound Dressing (DEVICE), ACTICOAT™ Antimicrobial Barrier Dressing (DRUG), Mepilex® Ag Silver Foam Dressing (DRUG).
Who is sponsoring clinical trial NCT01004055?
This trial is sponsored by Vomaris Innovations, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.